• The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality novel chemistry leads on a second neurological disease target
Cambridge, UK and Tokyo, Japan, 10th October 2023 – PharmEnable Therapeutics, a UK drug discovery company, and Sosei Heptares (TSE: 4565), the international biopharmaceutical company, announce they have expanded their collaboration to apply their respective technologies to drive novel drug discovery for a second neurological disease target.
Sosei…
In the world of life science logistics, precision and reliability are paramount. John Roach, a Life Science Logistics Technician at Biocair with over 15 years of experience, shares his insights into this critical profession.
When you think of a patient needing life-saving medicine, we often hail the medical professional administering it as the hero. But, we overlook the important journey that medicine takes and who ensures it gets there. The role of a Life Science Logistics Technician goes far beyond just driving - they ensure that the most critical and urgently needed medicines reach their…
Howard Group strengthens team with appointment of Thomas Bewes as Asset Manager Surveyor joins Cambridge-based property investor and developer
Cambridge, 05 October 2022: Property investment and development company Howard Group is delighted to announce the appointment of Thomas Bewes MRICS as Asset Manager.
Thomas, a chartered surveyor, joins Howard Group from JLL, where he spent the last five years, most recently in the Industrial & Logistics Agency team, with responsibility for a portfolio of clients across Hertfordshire and East Anglia. Prior to joining JLL, Thomas studied at the…
London, October 5, 2023 – On Tuesday night, Kadans Science Partner won the 2023 category for best Refurbished/Recycled Workplace from the British Council for Offices’ (BCO). The BCO is Britain’s leading member organisation for leading, debating and discussing the office sector within the UK.
In June this year Sycamore House in Stevenage was the recipient of the Midlands and Central England region award within this category culminating in the national awards ceremony in London on the 3rd October.
The building was unanimously acclaimed by the judging panel for its transformation…
Optimizing Smooth Muscle Cell Cryopreservation for Cardiovascular Research
AMSBIO, in collaboration with the University of Strathclyde (UK), announce the release of a poster that describes a comprehensive assessment of the effects of three different cryopreservation reagents (CELLBANKER® 1, CELLBANKER® 2 and commonly used 10% DMSO) on the viability and proliferative capacity of vascular smooth muscle cells (vSMCs)
Central to understanding the vascular remodelling that underlies cardiovascular diseases is the ability to perform reliable single-cell analysis of vSMCs. Large-scale solutions for…
Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development
Nomination of novel drug target based on insights generated through application of Verily’s Immune Profiler platform and Sosei Heptares’ GPCR-focused structure-based drug design expertise
Tokyo, Japan, London and Cambridge, UK, 4 October 2023 – Sosei Group Corporation ("Sosei Heptares"; TSE: 4565) and Verily, an Alphabet precision health technology company, today announced the successful validation and nomination of a first G-protein-coupled receptor (GPCR) target into early drug…
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization
Appointment of Vincent Smith, PhD, as Chief Technology Officer and Jessica Rich as VP Business Development
Follows Broken String’s successful $15M Series A fundraising round in September 20231
Will support development and commercialization strategy for INDUCE-seq DNA break-mapping platform
Cambridge, UK, 02 October 2023: Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are…
2 October 2023 - LifeArc, the self-funded, not-for-profit medical research organisation today announced the appointment of Stéphane Maikovsky as Interim Chief Executive Officer (CEO), succeeding Dr Melanie Lee who stepped down from the role last month.
Stéphane joined LifeArc as Chief Financial Officer (CFO) and Trustee in June 2022 to lead the organisation’s Finance, Investment, Early Ventures, Information Technology and Operational Effectiveness teams.
On taking up his new role, Stéphane said, "I am delighted to be leading this organisation to deliver our bold strategy, which will…
Global specialist in temperature-controlled logistics for life sciences, Biocair, has been awarded a 2023 EcoVadis silver medal for its overall achievements in sustainability. This is the second year that Biocair has achieved the silver medal from the esteemed sustainability rating provider.
EcoVadis is the leading provider of trusted business sustainability ratings with a global network of more than 100,000 rated companies. The EcoVadis methodology is based on international sustainability standards, like those from United Nations Global Impact (UNGC) and International Organization for…
Read the October eNews #lifescience newsletter here featuring:
✅ Welcome from Tony Jones, CEO
✅ Making the Most of Your Marketing Budget Through Engagement
✅ Understanding What You are Signing Up To in Life Science Contracts
✅ Transforming Employee Engagement Through Effective Communication
✅ Unveiling New Horizons in Paediatric Medicine Through Engagement